PRESS RELEASE published on 04/09/2025 at 07:30, 8 months 10 days ago Iute Group Starts Conditional Exchange And Cash Tender Offer For New EUR 2025/2030 Bonds Iute Group launches conditional exchange and cash tender offer for new EUR 2025/2030 Bonds, offering bondholders reinvestment or cash exit option. Minimum participation threshold set at EUR 75 million Iute Group Exchange Cash Tender Conditional Offer EUR 2025/2030 Bonds
PRESS RELEASE published on 04/09/2025 at 07:30, 8 months 10 days ago OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025 OSE Immunotherapeutics to present new data on Lusvertikimab's long-term benefits and safety in ulcerative colitis at DDW 2025, showcasing potential in autoimmune diseases Ulcerative Colitis Immuno-oncology Inflammatory Diseases OSE Immunotherapeutics Lusvertikimab
PRESS RELEASE published on 04/09/2025 at 07:01, 8 months 10 days ago Press release: Leonteq enters the market for listed leverage products in Switzerland Leonteq announces the market launch of listed leverage products in Switzerland, listing over 2,500 products on SIX Swiss Exchange and planning expansion on BX Swiss Switzerland Leonteq SIX Swiss Exchange Market Launch Listed Leverage Products
PRESS RELEASE published on 04/09/2025 at 07:00, 8 months 10 days ago ARYZTA issues AGM invitation ARYZTA AG issues invitation to Annual General Meeting (AGM) scheduled for 09.04.2025. The international bakery company is based in Schlieren, Switzerland, with operations worldwide SIX Swiss Exchange ARYZTA AG AGM Invitation Bakery Company Schlieren Switzerland
REGULATED PRESS RELEASE published on 04/09/2025 at 07:00, 8 months 10 days ago Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity Biophytis confirms the Phase 2 OBA Clinical Trial launch in obesity, continuing development of BIO101 to reduce muscle strength loss. Seeking pharmaceutical partner for co-development Biophytis BIO101 Obesity Pharmaceutical Partner Phase 2 OBA Clinical Trial
PRESS RELEASE published on 04/09/2025 at 07:00, 8 months 10 days ago Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2 Valneva and LimmaTech announce first vaccination in Phase 2 infant study of tetravalent Shigella vaccine candidate S4V2. Study aims to combat shigellosis, a deadly diarrheal disease Valneva Phase 2 Study Shigella Vaccine Shigellosis LimmaTech
PRESS RELEASE published on 04/09/2025 at 06:59, 8 months 10 days ago Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity Biophytis confirms the launch of the Phase 2 OBA Clinical Trial in Obesity in 2025. The study aims to evaluate the efficacy of BIO101 in reducing muscle strength loss caused by GLP-1 agonists in obese patients Biophytis BIO101 Obesity Muscle Strength Phase 2 OBA Clinical Trial
PRESS RELEASE published on 04/09/2025 at 06:40, 8 months 10 days ago Bondholder meetings approve amendments proposed by MBT Systems GmbH and Meyer Burger Technology AG Bondholder meetings approve proposed amendments by MBT Systems GmbH and Meyer Burger Technology AG for 2027 and 2029 convertible bonds, exceeding required threshold Convertible Bonds Amendments Meyer Burger Technology AG Bondholder Meetings MBT Systems GmbH
PRESS RELEASE published on 04/09/2025 at 06:30, 8 months 10 days ago First trading day of Cham Swiss Properties Cham Swiss Properties AG debuts on SIX Swiss Exchange after successful merger, now one of Switzerland's top real estate companies with CHF 1.6 billion portfolio. Targets sustainable growth and dividend distribution Merger Real Estate Portfolio Growth SIX Swiss Exchange Cham Swiss Properties AG
PRESS RELEASE published on 04/09/2025 at 04:00, 8 months 10 days ago QNX Now Powering WeRide's Next-Generation ADAS Platform QNX and WeRide collaborate to accelerate Software Defined Vehicles deployment for automotive industry with advanced ADAS technology integrated into Chery's EXEED Sterra ES and ET models in China QNX Chery Software Defined Vehicles WeRide ADAS Technology
Published on 12/20/2025 at 00:30, 3 hours 14 minutes ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 5 hours 44 minutes ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 9 hours 14 minutes ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 13 hours 4 minutes ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 14 hours 14 minutes ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/19/2025 at 22:03, 5 hours 41 minutes ago EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 6 hours 4 minutes ago IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 7 hours 9 minutes ago Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
Published on 12/19/2025 at 19:56, 7 hours 48 minutes ago Original-Research: European Lithium Limited (von First Berlin Equity Research GmbH): Buy
Published on 12/19/2025 at 08:30, 19 hours 14 minutes ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 07:00, 20 hours 44 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 1 day 9 hours ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Published on 12/18/2025 at 16:31, 1 day 11 hours ago In Brazil, ENGIE Fully Commissions Serra do Assuruá, Its Largest Wind Complex Worldwide